Marc S. Raab

机构：German Cancer Research Center, Heidelberg University, University Hospital Heidelberg

发表论文 615 篇 · 总被引 12798 次 · h-index 57

代表论文

Teclistamab-based induction treatment in transplant-eligible, newly diagnosed multiple myeloma: a phase 2 trial (2026 · Nature Medicine · 被引 2)
MCL‐1 inhibition triggers a largely reversible cardiac stress signature in a humanised mouse model (2026 · British Journal of Pharmacology)
Author Correction: Teclistamab-based induction treatment in transplant-eligible, newly diagnosed multiple myeloma: a phase 2 trial (2026 · Nature Medicine)
Clinical decision support in hematological malignancies using a case-grounded AI agent (2026 · Nature Medicine)
Supplementary Table S9 from Clinical Scores to Predict Toxicities and Outcomes in Patients with Multiple Myeloma Undergoing Bispecific T-cell Engager Therapy (2026)
Supplementary Table S3 from Clinical Scores to Predict Toxicities and Outcomes in Patients with Multiple Myeloma Undergoing Bispecific T-cell Engager Therapy (2026)